Pharma intelligence,
strategic decisions.
OIP PharmAnalyze® continuously tracks pharma companies: pipelines, First-in-Human trials, financials, patents, prices, approvals. The 360° view that turns competitive intelligence into evidence-based decisions.
Pipelines reveal what a company defends. First-in-Human trials reveal where it bets.
By enriching the 360° pharma view with First-in-Human trial tracking, PharmAnalyze® connects early human trials all the way to Phase III assets. You read a competitor's strategic intent before it becomes public, where conventional intelligence stops at Phase II or III.
What you track on each pharma company
Structured, traceable dimensions, updated quarterly.
R&D pipeline
Active assets by therapeutic area and development phase. Continuous reading of portfolio depth and bets.
Clinical trials & FIH
Ongoing trials tracking, including First-in-Human, to capture the earliest strategic bets of each company.
Financial results
Quarterly and annual filings, signals of budget reallocation, margins by therapeutic area.
Patents
Filing activity and expiration timelines that signal portfolio white spaces and upcoming competitive openings.
Multi-country prices
Comparable price trajectories and early price-cut signals across major markets, updated monthly.
Health Authority events
Approvals, rejections, and label changes from major health authorities worldwide, integrated with the full competitive view.
Five use cases, one shared data layer
Strategy, BD&L, Competitive Intelligence, Finance, and Portfolio Management teams operate on the same 360° view.
Continuous competitive intelligence
Build a living file on every pharma competitor, cross-referenced by therapeutic area. Identify investment shifts, portfolio rotations, and quiet exits from an indication.
Early detection through FIH New
Track first-in-human trials by company to spot future targets before they reach Phase II. Particularly valuable in precision oncology, immunology, and rare diseases.
Strategic committees and portfolio reviews
Prepare in hours a competitive map that is quantified, sourced, and traceable for executive committees and boards. Move past "best guess" on multi-million-dollar questions.
Due diligence and BD&L
Evaluate an acquisition target or a licensable asset: R&D profile, financial dynamics, patent position, multi-country price signals. All in a single workspace.
Launch monitoring and market access
Anticipate a direct competitor entering an indication, cross-reference upcoming approvals with price dynamics in target countries. Prepare field teams ahead of an adverse go-to-market.
The 360° view, built for decisions.
A single workspace across every dimension you track. Updated quarterly, every number sourced and traceable.
Amplify PharmAnalyze® with purpose-trained AI connectors.
Plug Claude, ChatGPT, or Copilot directly into OIP's certified data. PharmAnalyze® AI connectors are trained on the module's data schemas: they know a FIH is not a generic Phase I, an EMA approval is not an FDA approval. Every answer traces back to its official source, never to the open web.
Custom reports and dashboards
Ask in plain language for a HER2+ competitive report, a dashboard on a competitor's oncology pipeline, a multi-country pricing comparison. Generated in minutes, sourced end to end.
Smart alerts
Define your weak signals once: a new product entering the pipeline, a new indication, a phase change, an imminent approval, a price movement. Get notified when something moves, not when everything is quiet.
In-app copilot
Ask your questions directly inside PharmAnalyze®. The AI copilot answers with exact numbers and source links, no hallucinations.
Three concrete benefits, measurable in daily work
No universal numbers we cannot back up: operational gains your teams feel in the first weeks.
See earlier
With FIH tracking added to the pipeline, you identify a competitor's strategic bets the moment they enter the clinic. Not when they become a threat.
Decide on facts
Every number is traceable to its official source: filings, trial registries, regulatory authorities. Strategic committees stop arguing about data and start arguing about decisions.
Save time
What your teams used to assemble manually from 8 different sources is consolidated into one view. The time saved goes into interpretation, not aggregation.
See what your competitors are preparing, before the market does.
30 minutes to see PharmAnalyze® applied to your therapeutic areas and priority competitors, FIH included.
A value chain, not a suite of tools.
OIP PharmAnalyze® sits on OIP Databank®, the official-data backbone that powers the entire Ecosystem. Combined with OIP Discovery® (augmented science) and OIP Healthcare® (360° view of global healthcare systems), it forms the complete chain of pharma intelligence, from scientific signal to market signal.
Discover the OIP EcosystemOIP Databank®
The official-data backbone, 500+ curated sources.
OIP Healthcare®
360° view of global healthcare systems, 45 apps.
OIP Discovery®
Augmented science for R&D and medical teams.
OIP PharmAnalyze®
Pharma intelligence, strategic decisions.
